Contaminated drug causes vision loss for dozens of Pakistan diabetics
Dozens of diabetes patients in Pakistan suffered vision loss after being given a contaminated drug, a provincial health official said Tuesday.
Sep 26, 2023
0
39
MeSH tree: D12.776.124.486.485.114.224
Dozens of diabetes patients in Pakistan suffered vision loss after being given a contaminated drug, a provincial health official said Tuesday.
Sep 26, 2023
0
39
Pakistan's health minister said Sunday that an injectable medicine that was causing a severe eye infection and sight loss in diabetic patients in the province of Punjab has been recalled and an investigation ordered while ...
Sep 24, 2023
0
75
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern ...
Sep 22, 2023
0
90
Tennessee last year spent $48 million on a single drug, Humira—about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, ...
Sep 21, 2023
0
66
National medicine regulator, the Food and Drug Administration (FDA), recently approved the world's first vaccines to prevent RSV, or respiratory syncytial virus, for infants and elderly adults.
Sep 14, 2023
0
49
Researchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination with the drugs nivolumab, and regorafenib.
Ask Danielle Palmieri when her newborn son contracted RSV, and she doesn't give a season or even a month. She knows the exact day.
Sep 7, 2023
0
52
Doctors are seeing a spike in severe cases of respiratory syncytial virus (RSV) among young children in Florida and Georgia, U.S. health officials warned Tuesday.
Sep 6, 2023
0
32
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, ...
Aug 23, 2023
0
67
Research and development (R&D) costs for targeted oncology drugs are markedly lower if guided by a companion diagnostic strategy, but current biopharmaceutical business models suggest these savings will not be reflected in ...
Aug 21, 2023
0
56